Interferon Current Events | Interferon News | 4
|
| Page
4 of
6 |
119 Results |
|
|
|
Sort By:
Page Views | Date |
SEK 20 million for brain tumor research
The M'Īrit and Hans Rausing Charitable Foundation in England has awarded SEK 20 million over five years to a research team at the Faculty of Medicine at Lund University in Sweden. The team is conducting the so-called BRIGTT Project (BRain Immuno Gene Tumor Therapy), which is pursuing laboratory work and clinical research to try to find new methods... view more... (2003-06-25)
Scientists find predisposition to bronchiolitis in some babies
Scientists have found that a large proportion of infants who suffer from bronchiolitis have an inherent pre-disposition to the disease. view more (2007-10-22)
Vaccine May Complement Conventional Treatment For Chronic Leukaemia
A vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia (CML), suggest early results of a trial published in this week's issue of The Lancet. view more (2005-02-16)
New hope for multiple sclerosis sufferers
A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS). view more (2008-10-23)
Study unveils how West Nile virus evades immune defenses, points to vaccine development
West Nile virus evades the body's immune defenses by blocking immune signaling by a protein receptor, a finding that could pave the way for a vaccine to protect against North American strains of the virus. view more (2006-10-05)
Extending treatment after liver transplant may benefit patients with hepatitis C recurrence
Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study. view more (2009-11-02)
Researchers develop novel mouse model to witness immune system attack on chlamydia
Using a novel mouse model that allows scientists to study how the immune system's fighter cells respond to invaders in the genital tract during the initial stage of infection, Harvard Medical School (HMS) researchers have found a way to track immunity against Chlamydia trachomatis. view more (2006-07-25)
Discovery could improve hepatitis C treatment
Walter and Eliza Hall Institute researchers are part of an international team that has discovered a genetic variation that could identify those people infected with hepatitis C who are most likely to benefit from current treatments. view more (2009-09-24)
Longest ever follow-up study of a targeted cancer therapy shows excellent results
The overall survival of most people with chronic myelogenous leukemia (CML) treated with imatinib (Gleevec, STI-571) is extremely high and the relapse rate is quite low, according to new data from a study out of the Oregon Health & Science University Cancer Institute. view more (2006-06-05)
EuroDYNA takes lid off the genome
European researchers have made significant progress unravelling how genes are governed and why this sometimes goes wrong in disease. view more (2008-06-16)
A potential therapeutic strategy for hepatic failure
Fulminant hepatic failure is a serious clinical disease and may threaten the life of patients. However, because of the damage of mass liver cells, the organ function is often irreversible due to the liver cell degeneration, swelling, or apoptosis. Thus, to supply new sources of functional liver cells is a valuable choice for these patients. view more (2009-03-31)
Stem cells could halt osteoporosis, promote bone growth
While interferon gamma sounds like an outer space weapon, it's actually a hormone produced by our own bodies, and it holds great promise to repair bones affected by osteoporosis. view more (2009-03-05)
Poxvirus Potency Uncovered in New Atomic Map
Scientists at the University of Alabama at Birmingham (UAB) and Saint Louis University used X-ray crystallography to uncover new details about the infectious potency of poxviruses, furthering the understanding of how viral infections can subvert the body's immune system. view more (2008-02-04)
Preliminary study shows promise for treatment of renal cell cancer
A new study suggests that sunitinib is a promising agent for treatment of metastatic renal cell cancer, currently a disease without highly effective treatment options. view more (2006-06-07)
New therapeutic target identified for rheumatoid arthritis
Researchers at Hospital for Special Surgery have identified a potential new therapeutic target that could be used to treat inflammatory disorders, such as rheumatoid arthritis. view more (2008-11-05)
Immune system's distress signal tells bacteria when to strike back
The human opportunistic pathogen, Pseudomonas aeruginosa, has broken the immune system's code, report researchers from the University of Chicago, enabling the bacteria to recognize when its host is most vulnerable and to launch an attack before the weakened host can muster its defenses. view more (2005-07-29)
Making headway against hepatitis C: SLU study shows new drug combo effective in non-responders
Saint Louis University Liver Center scientists are presenting research today on a more effective way to treat hepatitis C patients who have been unresponsive to current drug therapies. view more (2006-10-30)
Natural, soy-based substance might help fight MS, Jefferson neuroscientists find
A natural substance made from soy appears to have amazing restorative powers when given to animals with a multiple sclerosis (MS)-like disease. view more (2006-12-13)
Monitoring the response to vaccination against melanoma
A new study published in PLoS Medicine this week describes a way to measure the immune response in people treated with an experimental vaccine to melanoma. view more (2005-09-20)
New study pinpoints unique genetic susceptibility for viral encephalitis
In the study, the researchers suggest that herpes simplex encephalitis may reflect a single gene immunodeficiency that confers susceptibility to herpes simplex virus, an idea that contrasts with the prevailing scientific theory of how genes work to make people vulnerable to infections. view more (2006-09-18)
|
|
| Page
4 of
6 |
119 Results |
|
|
|
Sort By:
Page Views | Date |
|
